Suppr超能文献

整蛋白和定义的 CD8(+) 和 CD4(+) 肽与穿透肽靶标结合,靶向 MHC Ⅰ类和Ⅱ类抗原呈递途径。

Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.

机构信息

Immunology and Vaccine Laboratory, Centre for Immunology, Burnet Institute, Melbourne, Victoria, Australia.

出版信息

Immunol Cell Biol. 2011 Nov;89(8):904-13. doi: 10.1038/icb.2011.13. Epub 2011 Mar 8.

Abstract

Cytoplasmic delivery and cross-presentation of proteins and peptides is necessary for processing and presentation of antigens for the generation of cytotoxic T cells. We previously described the use of the 16 amino acid peptide penetratin from the Drosophila Antennapedia homeodomain (penetratin, Antp) to transport cytotoxic T lymphocyte epitopes derived from ovalbumin (OVA) or the Mucin-1 tumor-associated antigen into cells. We have now shown that penetratin covalently conjugated to OVA protein and linked in tandem to CD4(+) and/or CD8(+) T-cell epitopes from OVA-stimulated T cells in vitro (B3Z T-cell hybridoma and OT-I and OT-II T cells). The induction of these responses was directly mediated by the penetratin peptide as linking a nonspecific 16-mer peptide to OVA or mixing did not induce CD8(+) or CD4(+) T-cell responses in vitro. Furthermore, interferon (IFN)-γ-secreting CD4(+) and CD8(+) T cells were induced which suppressed B16.OVA tumor growth in C57BL/6 mice. Tumor protection was mediated by a CD8(+) T-cell-dependent mechanism and did not require CD4(+) help to protect mice 7 days after a boost immunization. Alternatively, 40 days after a boost immunization, the presence of CD4(+) help enhanced antigen-specific IFN-γ-secreting CD8(+) T cells and tumor protection in mice challenged with B16.OVA. Long-term CD8 responses were equally enhanced by antigen-specific and universal CD4 help. In addition, immunization with AntpOVA significantly delayed growth of B16.OVA tumors in mice in a tumor therapy model.

摘要

细胞质内递呈蛋白和肽是加工和递呈抗原以产生细胞毒性 T 细胞所必需的。我们之前描述了利用果蝇触角同源域 16 个氨基酸肽 penetratin(penetratin,Antp)转导细胞毒性 T 淋巴细胞表位衍生自卵清蛋白(OVA)或黏蛋白 1 肿瘤相关抗原。我们现在发现,OVA 蛋白与 penetratin 共价结合并串联连接到体外 OVA 刺激的 T 细胞中的 CD4(+)和/或 CD8(+)T 细胞表位(B3Z T 细胞杂交瘤和 OT-I 和 OT-II T 细胞)。这些反应的诱导是由 penetratin 肽直接介导的,因为将非特异性 16 肽与 OVA 连接或混合不会在体外诱导 CD8(+)或 CD4(+)T 细胞反应。此外,诱导产生了 IFN-γ 分泌的 CD4(+)和 CD8(+)T 细胞,可抑制 C57BL/6 小鼠中的 B16.OVA 肿瘤生长。肿瘤保护是由 CD8(+)T 细胞依赖性机制介导的,在加强免疫后 7 天不需要 CD4(+)辅助来保护小鼠。或者,在加强免疫后 40 天,CD4(+)辅助的存在增强了针对抗原的 IFN-γ 分泌的 CD8(+)T 细胞和在受到 B16.OVA 挑战的小鼠中的肿瘤保护。针对抗原的和通用的 CD4 辅助均同等增强了长期 CD8 反应。此外,AntpOVA 免疫在肿瘤治疗模型中显著延迟了 B16.OVA 肿瘤的生长。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验